Dynamic contrast-enhanced MR evaluation of prostate cancer before and after endorectal high-intensity focused ultrasound;La risonanza magnetica perfusionale nella valutazione dell'adenocarcinoma della prostata prima e dopo HIFU transrettale

Radiologia Medica

Volumn 118, Issue 5, 2013, Pages 851-862

  Del Vescovo, R ^a   Pisanti, F ^b   Russo, V ^a   Battisti, S ^a   Cazzato, R L ^a   D'Agostino, F ^a   Giurazza, F ^a   Quattrocchi, C C ^a   Faiella, E ^a   Setola, R ^a   Giulianelli, R ^b   Grasso, R F ^a   Beomonte Zobel, B ^a  

^a UNIVERSITY OF ROME   (Italy)

^b Department of Urology ^*  (Italy)

Author keywords

D CE MR; DYCHO; HIFU; MRI; Prostate cancer

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOTERATE MEGLUMINE; MEGLUMINE; ORGANOMETALLIC COMPOUND; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; COMPUTER ASSISTED DIAGNOSIS; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CONTRAST MEDIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84884734580     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-012-0876-9     Document Type: Article

References (19)

1. Poissonnier L, Chapelon JY, Rouviere O et al (2007) Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 51:381-387
2. Watkin NA, ter Haar GR, Rivens I (1996) The intensity dependence of the site of maximal energy deposition in focused ultrasound surgery. Ultrasound Med Biol 22:483-491
3. Uchida T, Ohkusa H, Yamashita H (2006) Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 13:228-233
4. Beerlage HP, Thuroff S, Debruyne FM et al (1999) Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 54:273-277
5. Sibille A, Prat F, Chapelon JY et al (1993) Extracorporeal ablation of liver tissue by high-intensity focused ultrasound. Oncology 50:375-379
6. Chen L, ter Haar G, Hill CR (1997) Influence of ablated tissue on the formation of high-intensity focused ultrasound lesions. Ultrasound Med Biol 23:921-931
7. Chen L, ter Haar G, Hill CR et al (1993) Effect of blood perfusion on the ablation of liver parenchyma with high-intensity focused ultrasound. Phys Med Biol 38:1661-1673
8. Billard BE, Hynynen K, Roemer RB (1990) Effects of physical parameters on high temperature ultrasound hyperthermia. Ultrasound Med Biol 16:409-420
9. Padhani AR (2003) MRI for assessing antivascular cancer treatments. Br J Radiol 76(Spec No 1):S60-S80
10. Raman SS, Lu DS, Vodopich DJ et al (2000) Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 175:1253-1258
11. Russo V, Setola R, Del Vescovo R et al (2007) An innovative tool to dynamic contrast enhancement analysis. Conf Proc IEEE Eng Med Biol Soc 2007:63-66
12. Sinha AA, Quast BJ, Reddy PK et al (2004) Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Exp Mol Pathol 77:153-159
13. Padhani AR, Gapinski CJ, Macvicar DA et al (2000) Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99-109
14. Mueller-Lisse UG, Heuck AF, Schneede P et al (1996) Postoperative MRI in patients undergo-ing interstitial laser coagulation thermotherapy of benign prostatic hyperplasia. J Comput Assist Tomogr 20:273-278
15. Boni RA, Sulser T, Jochum W et al (1997)Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation. Radiology 202:232-236
16. Zlotta AR, Djavan B, Matos C et al (1998) Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. Br J Urol 81:265-275
17. Vellet AD, Saliken J, Donnelly B et al (1997) Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications. Radiology 203:653-659
18. Dromain C, de Baere T, Elias D et al (2002) Hepatic tumors treated with percutaneous radiofrequency ablation: CT and MR imaging follow-up. Radiology 223:255-262
19. Rouviere O, Lyonnet D, Raudrant A et al (2001) MRI appearance of prostate following trans-rectal HIFU ablation of localized cancer. Eur Urol 40:265-274